Prospettive Sociali e Sanitarie

Caroline D. Kim, Monique Seguin, Nadia Therrien, Geneviève Riopel, Nadia Chawky, Alain D. Lesage, and G.
Turecki
Familial Aggregation of Suicidal Behavior: A Family Study of Male Suicide Completers From the General Population
1017-1019
Communications and Updates
Letters to the Editor:
DEBORAH R. KIM and JEFFREY P. STAAB Quetiapine Discontinuation Syndrome 1020
LEONA YIP, AHMED MASHHOOD, and SUNÉ NAUDÉ Low IQ and Gasoline Huffing: The Perpetuation Cycle
1020-1021
MOHAMED RAHMAN and NADEEM HAIDER Anticonvulsant Hypersensitivity Syndrome From Addition of
Lamotrigine to Divalproex 1021
DANNY SULLIVAN, MARK WALTERFANG, and DENNIS VELAKOULIS Bipolar Disorder and Niemann-Pick
Disease Type C 1021-1022
ALICIA E.B. LAWRYNOWICZ and TIMOTHY D. BAKER Suicide and Latitude in Argentina: Durkheim Upside-
Down 1022
KATHARINE A. PHILLIPS Olanzapine Augmentation of Fluoxetine in Body Dysmorphic Disorder 1022-1023
KIM J. MASTERS Pilocarpine Treatment of Xerostomia Induced by Psychoactive Medications 1023
DIRK LICHTERMANN Cancer Risk in Parents of Patients With Schizophrenia 1024
SUSANNE OKSBJERG DALTON, THOMAS MUNK LAURSEN, LENE MELLEMKJAER, CHRISTOFFER
JOHANSEN, and PREBEN BO MORTENSEN Dr. Dalton and Colleagues Reply 1024-1025
JEFFREY A. MATTES Irritability and Depression 1025
GIOVANNI B. CASSANO Dr. Cassano Replies 1025
ASHLEY SMITH, ASHOK KUMAR JAINER, and CLAIRE BENNET Sertraline for Recurrent Major Depression
1025-1026
ARTHUR RIFKIN and WILLIAM DAVID RIFKIN Psychiatry and General Practitioners 1026
CHUAN-SHENG ZHAO, KIRSI PUURUNEN, JUHANI SIVENIUS, JUKKA JOLKKONEN, and TIMOTHY
SCHALLERT Psychotropic Medication and Stroke Outcome 1026-1027
MINNA M. RAIVIO, JOUKO V. LAURILA, TIMO E. STRANDBERG, REIJO S. TILVIS, and KAISU H. PITKÄLÄ
Psychotropic Medication and Stroke Outcome 1027
NATHAN HERRMANN, KRISTA L. LANCTÔT, and MUHAMMAD MAMDANI Dr. Herrmann and Colleagues
Reply 1027-1028
JONATHAN FOULDS and JILL WILLIAMS Tobacco Use and Cataracts in Patients With Schizophrenia 1028
THOMAS E. STEELE Tobacco Use and Cataracts in Patients With Schizophrenia 1028-1029
STEPHEN R. MARDER, SUSAN M. ESSOCK, ALEXANDER L. MILLER, ALAN FRIEDMAN, and MT. SINAI
CONFERENCE PARTICIPANTS Dr. Marder and Colleagues Reply 1029
MARIO SPERANZA, MAURICE CORCOS, OLIVIER GUILBAUD, GWENOLÉ LOAS, and PHILIPPE JEAMMET
Alexithymia, Personality, and Psychopathology 1029-1030
HANS JOERGEN GRABE, CARSTEN SPITZER, and HARALD J. FREYBERGER Dr. Grabe and Colleagues Reply
1030
J. MIGUEL PENA-ANDREU, ANDRES FONTALBA, MONICA CARRERA, J. LUIS MARTINEZ, and M. ISABEL
RODRÍGUEZ Refining the Personality Disorder Diagnosis 1030-1031
MARK A. AMDUR Comment on Hoarding 1031
SANJAYA SAXENA Dr. Saxena Replies 1031-1032
Book Forum:
PHILIP G. JANICAK Practical Management of Dementia: A Multi-Professional Approach 1033
MICHAEL R. BIEBER Alzheimer’s Disease: The Physician’s Guide to Practical Management 1033-1034
DANIEL P. van KAMMEN Schizophrenia Into Later Life: Treatment, Research, and Policy 1034-1035
RICHARD P. KLUFT Brief Treatments for the Traumatized: A Project of the Green Cross Foundation 1035
TRUCE T. ORDOÑA Posttraumatic Stress Disorders in Children and Adolescents Handbook 1035-1036
DONALD D. DENTON Posttraumatic Stress Disorder: Malady or Myth? 1036
JUDITH L. HERMAN Early Intervention for Trauma and Traumatic Loss 1036-1037
MARC GALANTER My Name Is Bill: Bill Wilson—His Life and the Creation of Alcoholics Anonymous 1037-1038
MARK S. GOLD and JOHN F. BRANDT Handbook of Clinical Alcoholism Treatment 1038-1039
ARON S. WOLF The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 3rd ed. 1039
WILLIAM R. FLYNN Dual Diagnosis • Psychosocial Treatments 1040
PAUL C. HORTON Children of Color: Psychological Interventions With Culturally Diverse Youth, 2nd ed. 1040-1041
RODRIGO A. MUÑOZ Clinician’s Guide to Cultural Psychiatry 1041-1042